Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Strümpellstr. 39, 04289, Leipzig, Germany.
Clin Res Cardiol. 2012 Mar;101(3):191-200. doi: 10.1007/s00392-011-0380-6. Epub 2011 Nov 10.
Previous studies analyzing the relation between time-to-reperfusion, infarct size, microvascular obstruction (MO) and infarct transmurality in patients with ST-elevation myocardial infarction (STEMI) reperfused by primary percutaneous coronary intervention (PCI) reported inconsistent results. Furthermore, it remains unclear, if transmural infarction is associated with adverse clinical outcome. The present study included STEMI patients reperfused by primary PCI (n = 322) within 720 min after symptom-onset undergoing contrast-enhanced magnetic resonance imaging (CMR) at a median of 3 days after the index event [interquartile range (IQR) 2-4]. Patients were subcategorized into tertiles according to time-to-reperfusion. Infarct size and MO were assessed approximately 15 min after gadolinium-injection. Infarct transmurality was assessed by a score with late-enhancement grading as <25, 25-50, 51-75 and >75% transmurality analyzing all 17 left ventricular segments. Clinical follow-up was performed after 20 months (IQR 13;29). The primary endpoint was defined as a composite of death and congestive heart failure. The median time-to-reperfusion was 230 min (IQR 153;390). Infarct size and MO did not increase significantly with longer time-to-reperfusion (p = 0.16 and p = 0.44, respectively). In contrast to infarct size and MO, the infarct transmurality score progressed significantly with increasing ischemic time (p < 0.001). In multivariable logistic regression analysis, time-to-reperfusion was identified as an independent predictor for transmural infarction (p = 0.03). However, transmural infarction was not predictive of the primary composite clinical endpoint (p = 0.22). In conclusion, in STEMI patients reperfused by primary PCI, time-to-reperfusion was an independent predictor for transmural infarction but not for infarct size and MO. However, transmural infarction was not predictive of death and congestive heart failure.
先前的研究分析了在症状发作后 720 分钟内接受直接经皮冠状动脉介入治疗(PCI)再灌注的 ST 段抬高型心肌梗死(STEMI)患者的再灌注时间、梗死面积、微血管阻塞(MO)和梗死透壁程度之间的关系,但结果不一致。此外,透壁性梗死是否与不良临床结局相关仍不清楚。本研究纳入了在症状发作后 720 分钟内接受直接 PCI 再灌注的 STEMI 患者(n=322),这些患者在指数事件后中位数 3 天(IQR 2-4)进行对比增强磁共振成像(CMR)检查。患者根据再灌注时间分为三组。在钆注射后大约 15 分钟评估梗死面积和 MO。通过一个评分系统评估梗死透壁程度,该评分使用晚期增强分级<25%、25%-50%、51%-75%和>75%透壁程度分析所有 17 个左心室节段。临床随访时间为 20 个月(IQR 13;29)。主要终点定义为死亡和充血性心力衰竭的复合终点。再灌注时间中位数为 230 分钟(IQR 153;390)。随着再灌注时间的延长,梗死面积和 MO 没有明显增加(p=0.16 和 p=0.44)。与梗死面积和 MO 不同,随着缺血时间的延长,梗死透壁程度评分显著增加(p<0.001)。在多变量逻辑回归分析中,再灌注时间被确定为透壁性梗死的独立预测因子(p=0.03)。然而,透壁性梗死对主要复合临床终点没有预测作用(p=0.22)。总之,在直接 PCI 再灌注的 STEMI 患者中,再灌注时间是透壁性梗死的独立预测因子,但不是梗死面积和 MO 的独立预测因子。然而,透壁性梗死不能预测死亡和充血性心力衰竭。